Edwards Lifesciences Reports Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
- S&P 500, Nasdaq close sharply higher as Broadcom rallies
- Oil prices settle at pre-Iran war levels as crude output grows
- Broadcom stock pops 4% as Apple silicon deal gets extended through 2031
- Buy the pullback in chip stocks, JPM's Matejka says
- Memory stocks rebound as analysts flag a buying opportunity
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Broadcom secures role as key Apple supplier with chip deal through 2031
Edwards Lifesciences (EW) Tops Q2 EPS by 17c, Offers Guidance
July 23, 2020 4:17 PM EDTEdwards Lifesciences (NYSE: EW) reported Q2 EPS of $0.34, $0.17 better than the analyst estimate of $0.17. Revenue for the quarter came in at $925 million versus the consensus estimate of $797.53 million.
GUIDANCE:
Edwards Lifesciences sees FY2020 EPS of $1.75-$1.95, versus the consensus of $1.63. Edwards Lifesciences sees FY2020 revenue of $4-4.5 billion, versus the consensus of $4.23... More
